Turkish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
American Journal of Hypertension 2004-Oct

Concealment of electrocardiographically based diagnosis of left ventricular hypertrophy by anasarca.

Sadece kayıtlı kullanıcılar makaleleri çevirebilir
Giriş yapmak kayıt olmak
Bağlantı panoya kaydedilir
John E Madias

Anahtar kelimeler

Öz

BACKGROUND

Diagnosis of left ventricular hypertrophy (LVH) is primarily based on measurements of R- and S-waves from various electrocardiographic (ECG) leads. Recent information has shown that anasarca peripheral edema (AN) (defined as fluid accumulation diagnosed by weight gain, positive fluid intake/output records, and pitting edema in the lower extremities and rest of the body, particularly in the dorsal region) leads to attenuation in the amplitude of QRS complexes and consequently could interfere with the diagnosis of LVH. The objective of this study was to evaluate whether the diagnosis of LVH is concealed by AN.

METHODS

Conventional ECG measurements and diagnostic binary characterization according to the Cornell, Sokolow-Lyon, and Romhilt-Estes systems were carried out in 14 patients with LVH (six patients with AN and eight patients admitted contemporaneously who did not gain weight during their hospitalization and who served as control subjects). The patients with AN were evaluated on admission (before the development of AN), and on the days of half of peak weight (HF-W) gain, peak weight (P-W) gain, and the lowest subsequent weight (L-W). The control subjects were evaluated on admission and at discharge. Analyses included the following: characterization by the three LVH diagnostic instruments mentioned previously; QRS amplitude measurements for the assessment of LVH before and after development of AN; and comparisons of the AN patients with the control subjects.

RESULTS

Measurements and binary characterization was diagnostic of LVH on admission by design for all 14 patients. However, although such characterization remained unaltered for the control subjects, the patients with AN revealed statistically significant drops in all ECG measurements on the days of HF-W gain (P = .016 to .0005) and P-W gain (P = .02 to .0005), at which points the diagnosis of LVH could no longer anymore substantiated.

CONCLUSIONS

The results of this study indicate that AN interferes with electrocardiographically based diagnosis of LVH. This has clinical implications because accurate characterization of the presence or absence of LVH is unattainable in patients with AN and should await abatement of the edematous state. The previously stated can be extrapolated to the patients with congestive heart failure who have gone on to develop right heart failure and AN, or to patients with end-stage renal failure who also reveal attenuation of the ECG QRS potentials at the stage of poor compensation of their edematous state.

Facebook sayfamıza katılın

Bilim tarafından desteklenen en eksiksiz şifalı otlar veritabanı

  • 55 dilde çalışır
  • Bilim destekli bitkisel kürler
  • Görüntüye göre bitki tanıma
  • Etkileşimli GPS haritası - bölgedeki bitkileri etiketleyin (yakında)
  • Aramanızla ilgili bilimsel yayınları okuyun
  • Şifalı bitkileri etkilerine göre arayın
  • İlgi alanlarınızı düzenleyin ve haber araştırmaları, klinik denemeler ve patentlerle güncel kalın

Bir belirti veya hastalık yazın ve yardımcı olabilecek bitkiler hakkında bilgi edinin, bir bitki yazın ve karşı kullanıldığı hastalıkları ve semptomları görün.
* Tüm bilgiler yayınlanmış bilimsel araştırmalara dayanmaktadır

Google Play badgeApp Store badge